Culemborg, Netherlands

Wilhelmientje Jetten

This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wilhelmientje Jetten. Retrieved from https://idiyas.com/inventor/wilhelmientje-jetten

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wilhelmientje Jetten: Innovator in Factor IIa Inhibitors

Introduction

Wilhelmientje Jetten is a notable inventor based in Culemborg, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Factor IIa inhibitors. His work has led to the filing of one patent, showcasing his innovative approach to medical science.

Latest Patents

Wilhelmientje Jetten holds a patent for Factor IIa inhibitors. This invention is crucial in the development of anticoagulant therapies, which are essential for treating various cardiovascular conditions. The patent reflects his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Jetten is associated with Akzo Nobel N.V., a leading global company in the field of paints and coatings. His role at the company has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Some of his notable coworkers include Johannes Wilhelmus Van Nispen and Henricus Carl Ottenheym. Their collaboration has fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Wilhelmientje Jetten's contributions to the field of pharmaceuticals, particularly through his patent on Factor IIa inhibitors, highlight his role as an influential inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…